Millipore Sigma Vibrant Logo

119140 Adenosine Receptor Agonist, NECA - CAS 35920-39-9 - Calbiochem

119140
価格&在庫状況を照会

概要

Replacement Information

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
119140-10MGCN
在庫状況検索中…
現在国内在庫なし現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      ガラスビン 10 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      Description
      OverviewA cell-permeable adenosine analog that acts a potent non-selective agonist of adenosine receptors (Ki = 14 nM, 20 nM, 2.4 µM and 6.2 nM for A1, A2A, A2B, A3, respectively). Increases intracellular cAMP production (EC50 = 3.1 µM in A2B expressing CHO cells). Shown to increase glucagon release in a dose-dependent manner and inhibit insulin release at low concentrations. Although at higher concentration some insulin release is observed. Also, displays a wide range adenosine-dependent effects, such as blocking platelet aggregation and inhibiting DNA synthesis. When administered at reperfusion, it is shown reduce infarction and block the formation of the mitochondrial permeability transition pore by activating p70S6 kinase.
      Catalogue Number119140
      Brand Family Calbiochem®
      Synonyms(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-N-ethyl-3,4-dihydroxytetrahydrofuran-2-carboxamide
      References
      ReferencesForster, K., et al. 2006. Basic Res. Cardiol. 101, 319.
      de Zwart, M., et al. 1998. Nucleosides Nucleotides. 17, 969.
      Phillis, J. et al. 1986, Pharm. Biochem. Behavior.24, 263
      Durcan, M. J., et al. 1989. Pharmacol Biochem Behav. 32, 487.
      Bacher, S., et al. 1982. Naunyn Schmiedebergs Arch Pharmacol. 329, 67.
      Cusack, N., et al. 1981. Br J Pharm.72, 443.
      Londos, C., et al. 1980. Proc Natl Acad Sci.77, 2551.
      Product Information
      CAS number35920-39-9
      FormWhite solid
      Hill FormulaC₁₂H₁₆N₆O₄
      Chemical formulaC₁₂H₁₆N₆O₄
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary Target K<sub>i</sub>14 nM
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Adenosine Receptor Agonist, NECA - CAS 35920-39-9 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      Adenosine Receptor Agonist, NECA - CAS 35920-39-9 - Calbiochem 試験成績書(CoA)

      タイトルロット番号
      119140

      参考資料

      参考資料の概要
      Forster, K., et al. 2006. Basic Res. Cardiol. 101, 319.
      de Zwart, M., et al. 1998. Nucleosides Nucleotides. 17, 969.
      Phillis, J. et al. 1986, Pharm. Biochem. Behavior.24, 263
      Durcan, M. J., et al. 1989. Pharmacol Biochem Behav. 32, 487.
      Bacher, S., et al. 1982. Naunyn Schmiedebergs Arch Pharmacol. 329, 67.
      Cusack, N., et al. 1981. Br J Pharm.72, 443.
      Londos, C., et al. 1980. Proc Natl Acad Sci.77, 2551.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision25-September-2019 JSW
      Synonyms(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-N-ethyl-3,4-dihydroxytetrahydrofuran-2-carboxamide
      DescriptionA cell-permeable adenosine analog that acts a potent non-selective agonist of adenosine receptors (Ki = 14 nM, 20 nM, 2.4 µM and 6.2 nM for A1, A2A, A2B, A3, respectively). Increases intracellular cAMP production (EC50 = 3.1 µM in A2B expressing CHO cells). Shown to increase glucagon release in a dose-dependent manner and inhibit insulin release at low concentrations. Although at higher concentration some insulin release is observed. Also, displays a wide range adenosine-dependent effects, such as blocking platelet aggregation and inhibiting DNA synthesis. When administered at reperfusion, it is shown reduce infarction and block the formation of the mitochondrial permeability transition pore by activating p70S6 kinase.
      FormWhite solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number35920-39-9
      Chemical formulaC₁₂H₁₆N₆O₄
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (50 mM)
      Storage +2°C to +8°C
      Protect from light
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesForster, K., et al. 2006. Basic Res. Cardiol. 101, 319.
      de Zwart, M., et al. 1998. Nucleosides Nucleotides. 17, 969.
      Phillis, J. et al. 1986, Pharm. Biochem. Behavior.24, 263
      Durcan, M. J., et al. 1989. Pharmacol Biochem Behav. 32, 487.
      Bacher, S., et al. 1982. Naunyn Schmiedebergs Arch Pharmacol. 329, 67.
      Cusack, N., et al. 1981. Br J Pharm.72, 443.
      Londos, C., et al. 1980. Proc Natl Acad Sci.77, 2551.